ロード中...
Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study
The COVID‐19 pandemic has manifold impacts on clinical trials. In response, drug regulatory agencies and public health bodies have issued guidance on how to assess potential impacts on ongoing clinical trials and stress the importance of a risk‐assessment as a pre‐requisite for modifications to the...
保存先:
| 出版年: | Pharm Stat |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8014297/ https://ncbi.nlm.nih.gov/pubmed/33594741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.2100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|